|
|
Volumn 345, Issue 4, 2001, Pages 283-284
|
|
A magic bullet for cancer - How near and how far?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
CD20 ANTIGEN;
CD22 ANTIGEN;
DIPHTHERIA TOXIN;
FC RECEPTOR;
IMMUNOGLOBULIN ANTIBODY;
IMMUNOTOXIN;
MONOCLONAL ANTIBODY;
PSEUDOMONAS EXOTOXIN;
RITUXIMAB;
TRASTUZUMAB;
TUMOR ANTIGEN;
B CELL LYMPHOMA;
B LYMPHOCYTE;
BACTERIOPHAGE;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
DRUG HALF LIFE;
EDITORIAL;
GENETIC ENGINEERING;
HAIRY CELL LEUKEMIA;
HUMAN;
IMMUNOGENICITY;
LEUKOCYTE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
ANTIBODIES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ENTEROTOXINS;
EXOTOXINS;
HUMANS;
IMMUNOTOXINS;
LEUKEMIA, HAIRY CELL;
NEOPLASMS;
PSEUDOMONAS;
|
|
EID: 0035954712
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200107263450409 Document Type: Editorial |
|
Times cited : (9)
|
|
References (12)
|
